# ShedRx reviews (2026): GLP-1 telehealth sellers | This GLP

The same page quotes the medication at $149 and at $349-499, and the membership at $99 and at $125, without ever reconciling either pair.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/shedrx
Updated: 2026-10-28

Partner By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 One page, two answers, twice

# ShedRx review

The same page quotes the medication at $149 and at $349-499, and the membership at $99 and at $125, without ever reconciling either pair.

## The verdict

ShedRx publishes $149 for an oral line plus a membership its own page states as both $99 and $125 a month, which makes the all-in $274 on the higher of the two. Its microdose injections open at $149 and $199 and carry a stated two-month minimum.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Orforglipron · Semaglutide · Tirzepatide

Form

Injection · Oral

Injection

From $149/mo

Oral

From $274/mo

Prescription

Required

Compounded

Yes — not FDA-approved

ShedRx routes some buyers to a manufacturer pharmacy and charges a membership alongside, sells its own compounded microdose injections of both molecules, and has added an orforglipron tablet — three quite different purchases sitting behind one storefront.

1.  ## Who writes the prescription, and what do they see?
    
    The membership is described as covering a provider fee, so the clinical relationship is priced separately from the medicine, and on the manufacturer-pharmacy route the medication is paid to a third party rather than to ShedRx at all.
    
    A storefront that cannot state its own membership fee consistently on a single page is not a storefront a reader should assume has settled anything else, and the inconsistency is the most important fact recorded about it.
    
2.  ## What happens when the dose goes up?
    
    The microdose lines sit below the doses the trials ran at and are described as microdose rather than by milligram, so a reader cannot tell where on the approved ladder either product sits.
    
3.  ## What the price includes
    
    On the oral route, $149 paid to the dispensing pharmacy plus the $125 membership comes to $274 a month, or $1,644 over six. The same arithmetic applies to the new orforglipron tablet at the same two figures. The compounded microdose injections are $149 for semaglutide and $199 for tirzepatide, each committing a buyer to at least two months, and the hero's $349-499 medication range would put the all-in far above any of it.
    
4.  ## What it claims, and what it cites
    
    The microdose lines are compounded and the manufacturer-pharmacy route is not, which puts two regulatory situations inside one catalog: a compounded preparation is not FDA-reviewed before dispensing, while the manufacturer's own pharmacy supplies the tested article.
    

## Where it holds up, and where it does not

-   Strength: Both a manufactured route and a compounded one are offered
-   Strength: The membership is disclosed rather than buried
-   Strength: An orforglipron tablet is priced openly
-   Strength: Cash-pay figures are published for new patients
-   Limitation: The membership is quoted at $99 and at $125 on one page
-   Limitation: The medication is quoted at $149 and at $349-499 on that same page
-   Limitation: Both microdose lines require a two-month minimum
-   Limitation: No milligram is published for either microdose product

## What the evidence says about this kind of treatment

The assessment above is about ShedRx. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader willing to telephone a seller and ask which of its two published membership fees is the real one.

Wrong for

A reader who needs one settled figure before enrolling, or who cannot commit two months at the outset.

## The evidence behind what ShedRx prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [What Is Orforglipron? A Daily GLP-1 Tablet That Is Not a Peptide](https://thisglp.com/research/what-is-orforglipron)
    
    A small-molecule daily tablet, not a peptide. Over 72 weeks in 3,127 adults, weight fell 11.2% on the top dose against 2.1% on placebo. No trial has compared it against an injection.
    
-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How ShedRx compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| TelePeptide | Readers who want the whole commitment ladder priced in advance |  |
| Midi Health | Readers who want every rung costed, with its milligram, before choosing a first dose |  |
| TrimRx | Readers who already know which molecule they want and will hunt for which tile holds it |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [TeleClinic](https://thisglp.com/reviews/teleclinic) [TeleDocs360](https://thisglp.com/reviews/teledocs360) [TeleHealth Med](https://thisglp.com/reviews/telehealth-med) [TeleHealth Weight Solutions](https://thisglp.com/reviews/telehealth-weight-solutions) [TeleSlim Clinic](https://thisglp.com/reviews/teleslim-clinic) [TeleZen MD](https://thisglp.com/reviews/telezen-md)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

What does the membership cost?

The page states $99 in one place and $125 in another. This site uses $125 in its all-in arithmetic, because choosing the lower figure would be resolving the seller's own contradiction in the seller's favor.

Can I cancel after a month?

Not on the microdose lines. Both state a two-month minimum, so neither is the cancel-anytime monthly rate the figure resembles.

What is the all-in on the oral route?

$274 a month — $149 paid to the dispensing pharmacy plus the $125 membership — assuming the higher of the two membership figures is the operative one.

Is ShedRx expensive compared with other GLP-1 telehealth sellers?

ShedRx publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts ShedRx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
